PRN Physician Recommended Nutriceuticals, a
premier producer of condition-specific omega-3 products and macular vitamins, and Scope
Ophthalmics, a leading distributor of innovative ophthalmic products in the UK, today
announced the launch of Omega Eye in the United Kingdom and Ireland. The introduction of
Omega Eye to the UK market is a significant enhancement to the treatments currently available
for patients suffering from dry eye symptoms. The product offers a daily dose of 2668mg of
omega-3 fatty acids in the re-esterified triglyceride form, including 1680mg of EPA and 560mg
of DHA, as well as 1000 IU of Vitamin D.
With the current UK dry eye market estimated at 13MM units/annum, the market is growing
at 12%/year. Experts say that this market will grow substantially in the coming years due
to the aging population in the UK and also the environmental changes that can lead to dry
eye symptoms. At present, 10% of the UK population suffers from some form of dry eye
sensation. As a result, omega-3 supplementation, already proving its value as an essential
part of dry eye therapy in the United States, is quickly becoming a topic of interest among UK
ophthalmologists.
source: PRN Neutriceuticals
2013-02-18
PRN Physician Recommended Nutriceuticals and Scope Ophthalmics launch Omega Eye in the UK
Subscribe to:
Post Comments (Atom)
2 comments:
paikka
I Interesting post. I have been wondering about this issue,so thanks for posting.
organic grocery
Hi There, I just spent a little time reading through your posts, which I found entirely by mistake whilst researching one of my projects. Please continue to write more because it’s unusual that someone has something interesting to say about this. Will be waiting for more!
Post a Comment